Ketoconazole ๐
โ ๏ธ Hepatotoxicity warning: Serious and sometimes fatal liver injury has occurred with oral ketoconazole, even at low doses.
Because of this, it should only be considered in the treatment of certain life-threatening systemic mycoses when no safer alternatives are available or tolerated.
๐ About
Synthetic imidazole antifungal.
Always check the BNF link here for up-to-date prescribing guidance.
โ๏ธ Mode of Action
- Inhibits fungal cytochrome P450 enzymes โ blocks ergosterol synthesis (disrupts fungal cell membrane).
- Also inhibits human CYP450 steroidogenic enzymes โ lowers cortisol and androgens (used off-label in Cushingโs disease โ ~50% response rate).
๐ Indications & Dose (specialist use)
- Systemic mycoses (oral use only if no alternative):
Blastomycosis, Coccidioidomycosis, Histoplasmosis, Chromomycosis, Paracoccidioidomycosis.
- Topical use: Superficial fungal infections (skin, dandruff, seborrhoeic dermatitis) โ generally safe.
๐ Interactions
- Potent inhibitor of CYP3A4 โ major drugโdrug interactions (โ levels of many drugs).
โ ๏ธ Cautions
- Concomitant use with drugs that prolong QT (e.g. dofetilide, quinidine, pimozide, cisapride).
- Monitor LFTs (ALT, AST, bilirubin, ALP), coagulation profile (PT/INR).
๐ซ Contraindications
- Should not be used as first-line treatment for any fungal infection.
- History of hepatic disease or previous hepatotoxicity with azoles.
โ Side Effects
- Hepatotoxicity: ~1 in 15,000 cases can be fatal.
- GI intolerance (nausea, vomiting, abdominal pain).
- QT prolongation โ risk of torsades de pointes.
๐ References